The impact of a pharmacist-extender training program to improve pneumococcal vaccination rates within a community chain pharmacy.
Journal
Journal of the American Pharmacists Association : JAPhA
ISSN: 1544-3450
Titre abrégé: J Am Pharm Assoc (2003)
Pays: United States
ID NLM: 101176252
Informations de publication
Date de publication:
Historique:
received:
09
03
2019
revised:
30
08
2019
accepted:
07
09
2019
pubmed:
2
11
2019
medline:
29
6
2021
entrez:
1
11
2019
Statut:
ppublish
Résumé
Evaluate the impact of a targeted training program for pharmacist-extenders (technicians and pharmacy interns) on vaccine screening role expansion within pharmacy workflow on pneumococcal vaccination rates. Secondary objectives include measuring changes in pharmacist-extenders' role perceptions surrounding vaccination services before and after training and exploring the implementation of vaccine screening role expansion of pharmacist-extenders using semistructured interviews founded in the Consolidated Framework for Implementation Research constructs. This study used a mixed methods sequential explanatory design from November 2017 to April 2018. The study occurred in 20 pharmacies in a division of a national supermarket, community pharmacy in Tennessee. Pharmacist-extenders, who worked in participating pharmacies and who completed the vaccination training program, before or after online survey or interview were included in this study. Pharmacist-extenders accessed a training program webinar. Onsite training focused on identifying eligible patients for pneumococcal vaccines based on patient age and comorbidities. The vaccine screening program used a train-the-trainer model. Pneumococcal vaccination rates were collected and analyzed from January 2018 to March 2018 and compared during the same time period from the previous year. Descriptive and inferential statistics evaluated pneumococcal vaccination rates and survey responses. An anonymous electronic Likert-type scale questionnaire was e-mailed to participating pharmacies before and after the training program. An explanatory qualitative arm was added post-hoc to provide insights into the primary endpoint. Six semistructured interviews were conducted using Consolidated Framework for Implementation Research domains. Pneumococcal vaccination rates improved compared with the previous year during the same time period (P > 0.05). Subgroup analysis identified outlier pharmacies prompting the explanatory qualitative arm. No statistically significant changes were identified in the surveys. Seven themes were identified from participant interviews. Pneumococcal vaccination rate data showed varying trends toward pharmacist-extenders having a positive impact on pneumococcal vaccination rates through role expansion; however, these improvements varied by pharmacy and were dependent on program implementation differences.
Identifiants
pubmed: 31669416
pii: S1544-3191(19)30420-0
doi: 10.1016/j.japh.2019.09.004
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
39-46Informations de copyright
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.